Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs AskRx

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, AskRx a 74. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

AskRx

#144 · Grade C+ · Watch List

Est. first month

From $199/mo (brand-name)

Get this deal Full AskRx review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 74 an est. $99/mo first month, with no teaser step-up baked in. AskRx isn't out of it: People who want a brand-name-only GLP-1 prescriber routing to NovoCare or LillyDirect.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDAskRx
Value Score89 (A)74 (C+)
Est. first month$99/moFrom $199/mo (brand-name)
Save vs brand-name~93%
Semaglutide$99/moFrom $199/mo (brand-name)
Tirzepatide$139/moFrom $299/mo (2.5 mg dose, brand-name)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
72
bmiMD: 95. AskRx: 72.
84
No Teaser-Rate Bait
54
bmiMD: 84. AskRx: 54.
98
Nationwide Availability
96
bmiMD: 98. AskRx: 96.
94
Both Molecules
92
bmiMD: 94. AskRx: 92.
82
Easy Cancellation
68
bmiMD: 82. AskRx: 68.
70
Reputation
80
bmiMD: 70. AskRx: 80.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

AskRx

AskRx is a US telehealth platform whose board-certified physicians exclusively prescribe FDA-approved, brand-name GLP-1 medications for weight loss - no compounded drugs.

Why it's a deal

  • Prescribes only FDA-approved brand-name GLP-1s, no compounded drugs
  • LegitScript approved and HIPAA compliant
  • Board-certified physicians trained in obesity medicine
  • Transparent dose-based pricing published on site
  • Available in all 50 states

The fine print

  • Cash-pay model; medication cost billed separately by the pharmacy
  • Does not dispense medication itself, so fulfillment depends on third-party pharmacies
  • No compounded lower-cost alternative offered
  • Specific list of supported states is not published
Get the bmiMD deal Get the AskRx deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to AskRx.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.